Pembrolizumab in patients from China with microsatellite instability-high/mismatch repair deficient tumors: KEYNOTE-158

Author:

Xu Jianming1,Mao Yimin2,Xu Nong3,Bai Yuxian4,Wang Dong5,Chen Xiaojun6,Yin Xianli7,Deng Yanhong8,Yang Jianwei9,Zhang Jieqing10,Tang Jie7,Huang Yi11,Li Jiayi12,Luo Suxia13,Zheng Hong14,Zhao Weidong15,Xu Miaomiao16,Li Nan16,Mao Yixiang17,Gozman Alexander18,Wu Xiaohua19

Affiliation:

1. Fifth Medical Center of CPLA General Hospital, Beijing, China

2. Renji Hospital Shanghai Jiaotong University School of Medicine, Shanghai, China

3. The First Affiliated Hospital Zhejiang University, Hangzhou, China

4. Harbin Medical University Cancer Hospital, Harbin, China

5. Chongqing University Cancer Hospital, Chongqing, China

6. Obstetrics & Gynecology Hospital of Fudan University, Shanghai, China

7. Hunan Cancer Hospital, Changsha, China

8. The Sixth Affiliated Hospital of Sun Yat-sen University, Guangzhou, China

9. Fujian Provincial Cancer Hospital, Fuzhou, China

10. Affiliated Cancer Hospital of Guangxi Medical University, Nanning, China

11. Hubei Cancer Hospital, Wuhan, China

12. The First Affiliated Hospital of Xiamen University-Oncology, Xiamen, China

13. Henan Cancer Hospital, Zhengzhou, China

14. Beijing Cancer Hospital, Beijing, China

15. Anhui Provincial Hospital-Obstetrics & Gynecology, Hefei, China

16. MSD (China) Co., Ltd, Beijing, China

17. MSD (China) Co., Ltd, Shanghai, China

18. Merck & Co., Inc., Rahway, NJ, USA

19. Fudan University Shanghai Cancer Center, Shanghai, China

Funder

Merck

Publisher

Informa UK Limited

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3